GLP-1 Food Market

Overview

The global GLP-1 Food Market was valued at USD 3.9 billion in 2025 and is projected to reach USD 19.8 billion by 2034, growing at a CAGR of 19.7% during the forecast period (2026–2034).  The market growth is driven by rising GLP-1 drug adoption, increasing demand for high-protein and satiety-focused foods, growing consumer interest in weight-management nutrition, expansion of functional and portion-controlled food products. The market is shifting from opportunistic labeling of existing products toward purpose-built product development and portfolio consolidation through acquisition. Early industry responses, exemplified by badges applied to existing product lines, are giving way to dedicated brand platforms engineered from formulation through packaging specifically for the GLP-1 consumer.  Government initiatives are shaping product claims and category credibility rather than providing direct subsidization. In the United States, the USDA reviewed and approved 'GLP-1 friendly' labeling claims used by major CPG manufacturers in January 2026, requiring that such claims be substantiated by verifiable protein and fiber content rather than implying therapeutic equivalence.  North America held the largest share of the GLP-1 Food Market in 2025, supported by the world's highest concentration of GLP-1 prescriptions and the fastest pace of CPG product launches. Europe is projected to be the fastest-growing region through 2034, driven by accelerating GLP-1 reimbursement decisions, strong direct-to-consumer complete-nutrition demand, and expanding retail distribution of high-protein and meal-replacement brands across Western Europe.

Market Size & Share

Market Dynamics

KEY MARKET TREND

Convergence of Big Food M&A and Purpose-Built Complete-Nutrition Platforms Emerging as a Transformational Trend

• Major food and beverage manufacturers are acquiring or fully consolidating direct-to-consumer complete-nutrition brands rather than relying solely on organic product development, reshaping competitive dynamics across the category.
• Formulation innovation is shifting toward nutrient-dense, protein- and fiber-fortified products delivered in convenient ready-to-drink, ready-to-eat, and single-serve formats matched to the smaller appetites of GLP-1 users.
• Retailers and foodservice chains are adopting dedicated in-store badges and menu sections to help GLP-1 users identify suitable products, increasing competitive pressure on brands without a differentiated GLP-1 proposition.
• Nestlé completed the acquisition of the remaining 51% stake in yfood Labs, valuing the European ready-to-drink meal-replacement brand at approximately USD 523 million, roughly three months after Danone's approximately USD 1.2 billion acquisition of Huel

KEY MARKET DRIVER

Rapid Global Adoption of GLP-1 Receptor Agonist Medications is the Key Driver

• Expanding global prescription volumes for GLP-1 medications such as semaglutide and tirzepatide are creating a large and growing base of consumers who require nutrient-dense, portion-controlled food options to manage appetite suppression and reduced caloric intake.
• Emerging clinical evidence linking GLP-1 therapy to accelerated loss of lean muscle mass and micronutrient deficiencies is increasing demand for high-protein and fortified food products among patients and prescribing clinicians.
• Weight-management and telehealth platforms are increasingly bundling structured nutrition-support programs with medication access, embedding food and nutrition guidance directly into the GLP-1 treatment pathway.
• Kraft Heinz reported a 22% increase in research and development spending in 2026, directed in part toward protein-, fiber-, and hydration-focused product innovation across its portfolio

KEY MARKET OPPORTUNITY

Restructuring of Legacy Weight-Management Brands Around GLP-1 Positioning Creates New Growth Opportunity

• Legacy weight-management and meal-replacement brands are changing ownership and being repositioned to align with GLP-1 demand, creating openings for both incumbent nutrition companies and new entrants in a restructuring category.
• Growth in employer- and health-plan-sponsored weight-management benefits is creating a new institutional distribution channel for GLP-1-aligned nutrition products alongside medication coverage.
• Growth of private-label and regional GLP-1-aligned product lines presents opportunities for retailers and mid-sized manufacturers that lack the acquisition capital available to global CPG leaders.
• Glanbia plc divested its SlimFast brand, selling the North American business to Heartland Food Products Group and the UK/European business to Supreme plc for approximately GBP 27 million, with Supreme citing SlimFast's positioning to capitalize on growing GLP-1-driven demand as its rationale.

GLP-1 Food Market Size, 2025–2034 (USD Billion)

Segmentation Analysis

Analysis by Product Type

High-Protein Foods held the largest market share in 2025 because muscle-mass preservation has become the primary nutritional concern for GLP-1 users, and high-protein ready meals, snacks, and dairy products offer the most direct, familiar way to address it. Retailers and manufacturers have prioritized reformulating existing high-protein lines and adding GLP-1-specific labeling to established products, giving this segment the fastest route to shelf and the broadest existing distribution base across grocery, club, and foodservice channels.

Complete Nutrition is projected to grow at the fastest CAGR during the forecast period, driven by acquisitions of direct-to-consumer brands such as Huel and food by major food groups and by consumers' need for convenient, nutritionally balanced products that deliver a full spectrum of protein, fiber, vitamins, and minerals in a single serving suited to smaller GLP-1-reduced appetites. Product innovation focused on higher protein, increased fiber, and improved micronutrient density is therefore expected to accelerate growth in this segment.

Product Type categories include

• High-Protein Foods (Dominating Segment)
• Complete Nutrition (Highest CAGR Segment)
• Functional Beverages
• Low-Calorie Portion-Controlled Snacks
• Nutritional Supplements

Analysis by Form

Ready Meals held the largest market share in 2025 because they solve portion control and nutrient density in a single purchase, closely matching the reduced but nutritionally demanding eating pattern of GLP-1 users. Frozen and refrigerated ready-meal platforms from established food manufacturers benefit from existing cold-chain distribution and strong retail relationships, allowing rapid rollout of GLP-1-labeled variants without new manufacturing investment.

Shakes are projected to grow at the fastest CAGR during the forecast period, supported by the acquisition-driven expansion of complete-nutrition brands and rising consumer preference for quick, easily digestible formats that reduce the burden of meal preparation for individuals experiencing GLP-1-related appetite suppression and nausea. Growing availability of ready-to-drink and powdered formulations, combined with increasing product innovation targeting higher protein content and improved taste and texture, is expected to further accelerate demand.

Form categories include

• Ready Meals (Dominating Segment)
• Shakes (Highest CAGR Segment)
• Snacks
• Beverages
• Others

Analysis by Distribution Channel

Hypermarkets held the largest market share in 2025 because they remain the primary purchase point for packaged food across all major markets, and GLP-1-labeled products have been rolled out first within existing grocery planograms rather than through new standalone channels. Wide retail footprint and established replenishment infrastructure give this channel the broadest reach among mainstream consumers new to GLP-1 therapy. Rising adoption of online grocery and direct-to-consumer platforms is expected to strengthen digital channels during the forecast period, but hypermarkets are likely to retain a leading position due to their accessibility, product assortment, and established consumer purchasing habits.

E-Commerce is projected to grow at the fastest CAGR during the forecast period, driven by subscription-based complete-nutrition brands, telehealth platforms that bundle nutrition products with medication access, and consumers' preference for discreet, direct home delivery of GLP-1-aligned food and supplement products. The integration of digital health platforms, mobile applications, and subscription services is expected to further strengthen customer retention and encourage repeat purchases among consumers following long-term GLP-1 treatment programs.

Distribution Channel categories include

• Hypermarkets (Dominating Segment)
• E-Commerce (Highest CAGR Segment)
• Nutrition Stores
• Foodservice

Analysis by Consumer Segment

Weight Management Seekers held the largest market share in 2025 because this group extends well beyond individuals with active GLP-1 prescriptions to include consumers pursuing similar high-protein, low-calorie eating patterns independently, giving manufacturers a broader addressable base for GLP-1-adjacent product positioning across mainstream retail. Growing awareness of protein intake, portion control, and nutrient density is further encouraging this segment to adopt convenient foods that support weight-management objectives, strengthening its contribution to overall market demand.

GLP-1 Drug Users are projected to grow at the fastest CAGR during the forecast period, tracking the rapid expansion of GLP-1 prescription volumes and the growing integration of nutrition products directly into telehealth and clinical weight-management programs targeted specifically at this cohort. Manufacturers are therefore expanding products such as high-protein shakes, complete-nutrition beverages, fortified snacks, and fiber-rich foods designed to support nutritional intake during GLP-1 treatment, further accelerating demand within this consumer segment.

Consumer Segment categories include

• Weight Management Seekers (Dominating Segment)
• GLP-1 Drug Users (Highest CAGR Segment)
• Diabetic Patients
• General Wellness Consumers

By Region

GLP-1 Food Market Share 2025, (CAGR)

North America

48%

South America

xx%

Europe

27%

Middle East Africa

xx%

Asia Pacific

xx%

North America held the largest share market in 2025, supported by an estimated 30–40 million active GLP-1 medication users in the United States and the fastest pace of CPG product launches globally. Major manufacturers including Nestlé, Conagra, and Simply Good Foods are headquartered in or maintain primary commercial operations across the region, giving it first-mover advantage in reformulation and labeling. The USDA's January 2026 review of 'GLP-1 friendly' claims provided regulatory clarity that has encouraged further product launches. Retail infrastructure for frozen meals, protein snacks, and nutrition bars is highly developed, and telehealth-integrated weight-management platforms such as WeightWatchers' Med+ program are expanding institutional and employer-sponsored distribution channels. Canada is following a similar adoption pattern at a smaller scale.

Europe is projected to grow at the fastest CAGR during the forecast period, driven by rising GLP-1 prescription volumes, strengthening reimbursement frameworks in select national health systems, and rapid growth of home-grown complete-nutrition brands. The United Kingdom is a key growth market, with Huel reporting UK sales growth of 26.5% and distribution across more than 17,000 stores prior to its acquisition by Danone. Germany hosts yfood, acquired in full by Nestlé in 2026, reflecting the region's strength in ready-to-drink meal-replacement innovation. Regulatory bodies across the European Union continue to apply existing nutrition and health-claims frameworks to GLP-1-linked marketing, while national health authorities in several member states are issuing nutrient-adequacy guidance for patients on GLP-1 therapy, further legitimizing the category.

Countries and Region Covered

North America (Largest Region)

• United States (Largest Country Market)
• Canada
• Mexico

Europe

• Germany
  
• United Kingdom
  
• France
  
• Italy
  
• Rest of Europe

Asia Pacific (Fastest Growing Region)

• China (Fastest Growing Country Market)
  
• India
  
• Japan
  
• South Korea
  
• Rest of Asia Pacific

Latin America

• Brazil
  
• Chile
  
• Rest of Latin America

Middle East and Africa

• Saudi Arabia
  
• United Arab Emirates
  
• Rest of Middle East and Africa

Market Share

The market is fragmented, combining a small number of large global consumer packaged goods groups with an expanding population of nutrition, functional food, and weight-management specialists. Nestlé, Danone, Conagra Brands, The Simply Good Foods Company, Herbalife, General Mills, PepsiCo, Abbott Laboratories, BellRing Brands, Lactalis Group, Lifeway Foods, Medifast, Chobani, The Campbell’s Company, and Tyson Foods are among the key players shaping the competitive landscape. Nestlé, Danone, Conagra Brands, General Mills, PepsiCo, and The Simply Good Foods Company hold strong positions through established retail distribution, broad food and nutrition portfolios, and products positioned around higher protein, fiber, portion control, and nutritional support for consumers using GLP-1 medications. Herbalife and Medifast strengthen the weight-management segment through specialized nutrition programs and products, while Abbott Laboratories and BellRing Brands leverage established clinical and sports-nutrition capabilities to address increased demand for protein-rich nutrition. At the same time, companies such as Lifeway Foods, Chobani, Lactalis Group, The Campbell’s Company, and Tyson Foods are expanding or repositioning high-protein, nutrient-dense food offerings to capture changing consumer preferences associated with GLP-1 therapy. Key success factors include verifiable protein and fiber content, regulatory-compliant labeling, scalable retail and e-commerce distribution, product convenience, and alignment with broader weight-management and nutrition programs. Leading companies are prioritizing product reformulation, development of GLP-1-oriented food and beverage products, expansion of high-protein and high-fiber portfolios, strategic acquisitions and partnerships, and integration with digital health, telehealth, pharmacy, and weight-management ecosystems to secure long-term positioning in the category.

Key Players

• Nestlé S.A. (Switzerland)
• Danone S.A. (France)
• Conagra Brands, Inc. (United States)
• The Simply Good Foods Company (United States)
• Herbalife Ltd. (United States)
• General Mills, Inc. (United States)
• PepsiCo, Inc. (United States)
• Abbott Laboratories (United States)
• BellRing Brands, Inc. (United States)
• Lactalis Group (France)
• Lifeway Foods, Inc. (United States)
• Medifast, Inc. (United States)
• Chobani, LLC (United States)
• The Campbell's Company (United States)
• Tyson Foods, Inc. (United States)

Recent Market Developments

• March 2025: NFRA study found that GLP-1 users are increasingly choosing high-protein, low-carb, and portion-controlled frozen foods, creating growth opportunities for food manufacturers and retailers.
• October 2025: Todo launched reformulated ready-to-drink high-protein and high-fiber shakes targeting the growing GLP-1 nutrition market, offering 26 grams of protein and 6 grams of prebiotic fiber.
• October 2025: Supreme plc acquired the UK and European SlimFast business from Glanbia for approximately GBP 27 million, stating explicitly that SlimFast is positioned to capitalize on growing demand for nutrition and protein supplementation among GLP-1 medication users.
• March 2026: Danone announced an agreement to acquire complete-nutrition brand Huel for approximately EUR 1 billion (USD 1.2 billion), citing the convergence of health-conscious eating and GLP-1-driven demand as a strategic rationale.
  

Frequently Asked Questions

Key Questions Answered

Request a Sample

1

What is a GLP-1 friendly food?

2

What is the CAGR of the GLP-1 Food Market?

3

Which product type leads the GLP-1 Food Market?

4

Which distribution channel is growing fastest in the GLP-1 Food Market?

5

Which consumer segment has the highest share?

6

What are the latest trends in the GLP-1 Food Market?

7

Who are the end users of GLP-1 foods?

Why Choose IG Transformation

Speak to Analyst

Strong Industry Focus

Extensive Product Offerings

Customer Research Services

Robust Research Methodology

Comprehensive Reports

Latest Technological Developments

Value Chain Analysis

Potential Market Opportunities

Growth Dynamics

Quality Assurance

Post-sales Support

Regular Report Updates